Blake Byers

Blake Byers is a seasoned entrepreneur and investor in technology and biotechnology companies. He co-founded NewLimit, a company focused on developing medicines to restore youthful function in old cells through epigenome reprogramming, with the goal of extending human healthspan. Prior to NewLimit, Blake was a partner at GV (formerly Google Ventures) for a decade, where he played a pivotal role in scaling the firm and investing in numerous successful startups. He holds a PhD in Bioengineering from Stanford University and has a track record of investing in early-stage ambitious founders, contributing to 8 IPOs and counting.